DrRichard Kelwick

Dr Richard Kelwick is a senior research associate and former Royal Society of Edinburgh Enterprise Fellow with research interests in synthetic biology, cell-free gene expression systems and extracellular vesicle biology.

Dr Kelwick has a Ph.D. in cancer biology in which he researched the roles of metalloproteinases in cancer. Specifically, investigating the protective mechanisms of A Disintegrin and Metalloproteinase with Thrombospondin motifs 15 (ADAMTS-15) in breast cancer. Dr Kelwick joined Prof. Paul Freemont’s group in 2013 where he has developed expertise in synthetic biology including the development of biosensors, biological materials and cell-free gene expression systems. Moving forward, Dr Kelwick aims to apply his expertise in both cancer biology and synthetic biology towards the development of novel extracellular vesicle (EV) biosensors and isolation methods for industrial applications.

>Author of peer reviewed publications that span my research interests in synthetic biology, cancer biology and EV biology.

>Member of Imperial Postdocs and Fellows Enterprise Network (IPFEN) Committee

>Successful entries in several business competitions (including Cancer Tech Accelerator 2021, Techcelerate 2018, OneStart 2016 and Lean Launchpad 2015 with Steve Blank and Jerome Engel). Also, founding president of the UEA Enterprise and Engagement Club [2010 - 2012].

>External speaker at University of Cambridge, University of Oxford, several Kenyan research institutions, and at national and international scientific conferences (e.g. GSEV-UKEV 2020, UKEV 2019, IET 2016, ECCSB 2017 [Switzerland]).

>A passion for science communication and public engagement. Interviewed on Persian TV (Manoto 1). Organised or supported events in the Science Museum, V&A museum, Tate Modern, Google London Campus, the Imperial Festival [2016; 2017] and at Harris City Academy Crystal Palace. Advisor of several iGEM teams.